Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 243
Filtrar
Más filtros

Tipo del documento
Colección Odontología Uruguay
Intervalo de año de publicación
1.
Antimicrob Agents Chemother ; 66(12): e0082022, 2022 12 20.
Artículo en Inglés | MEDLINE | ID: mdl-36326246

RESUMEN

To report on the therapy used for penicillin- and cephalosporin-resistant pneumococcal meningitis, we conducted an observational cohort study of patients admitted to our hospital with pneumococcal meningitis between 1977 and 2018. According to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) recommendations, we defined pneumococci as susceptible and resistant to penicillin with MIC values of ≤0.06 mg/L and > 0.06 mg/L, respectively; the corresponding values for cefotaxime (CTX) were ≤0.5 mg/L and >0.5 mg/L. We treated 363 episodes of pneumococcal meningitis during the study period. Of these, 24 had no viable strain, leaving 339 episodes with a known MIC for inclusion. Penicillin-susceptible strains accounted for 246 episodes (73%), penicillin-resistant strains for 93 (27%), CTX susceptible for 58, and CTX resistant for 35. Nine patients failed or relapsed and 69 died (20%), of whom 22% were among susceptible cases and 17% were among resistant cases. During the dexamethasone period, mortality was equal (12%) in both susceptible and resistant cases. High-dose CTX (300 mg/Kg/day) helped to treat failed or relapsed cases and protected against failure when used as empirical therapy (P = 0.02), even in CTX-resistant cases. High-dose CTX is a good empirical therapy option for pneumococcal meningitis in the presence of a high prevalence of penicillin and cephalosporin resistance, effectively treating pneumococcal strains with MICs up to 2 mg/L for either penicillin or CTX.


Asunto(s)
Cefalosporinas , Meningitis Neumocócica , Humanos , Cefalosporinas/uso terapéutico , Cefalosporinas/farmacología , Meningitis Neumocócica/tratamiento farmacológico , Penicilinas/farmacología , Penicilinas/uso terapéutico , Ceftriaxona/farmacología , Estudios de Cohortes , Cefotaxima/uso terapéutico , Cefotaxima/farmacología , Streptococcus pneumoniae , Pruebas de Sensibilidad Microbiana , Monobactamas/farmacología , Resistencia a las Penicilinas , Mitomicina/farmacología , Mitomicina/uso terapéutico , Antibacterianos/farmacología , Antibacterianos/uso terapéutico
2.
Environ Res ; 204(Pt B): 112021, 2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-34516978

RESUMEN

BACKGROUND: Associations of arsenic (As) with the sum of 5-mC and 5-hmC levels have been reported; however, As exposure-related differences of the separated 5-mC and 5-hmC markers have rarely been studied. METHODS: In this study, we evaluated the association of arsenic exposure biomarkers and 5-mC and 5-hmC in 30 healthy men (43-55 years) from the Aragon Workers Health Study (AWHS) (Spain) and 31 healthy men (31-50 years) from the Folic Acid and Creatinine Trial (FACT) (Bangladesh). We conducted 5-mC and 5-hmC profiling using Infinium MethylationEPIC arrays, on paired standard and modified (ox-BS in AWHS and TAB in FACT) bisulfite converted blood DNA samples. RESULTS: The median for the sum of urine inorganic and methylated As species (ΣAs) (µg/L) was 12.5 for AWHS and 89.6 for FACT. The median of blood As (µg/L) was 8.8 for AWHS and 10.2 for FACT. At a statistical significance p-value cut-off of 0.01, the differentially methylated (DMP) and hydroxymethylated (DHP) positions were mostly located in different genomic sites. Several DMPs and DHPs were consistently found in AWHS and FACT both for urine ΣAs and blood models, being of special interest those attributed to the DIP2C gene. Three DMPs (annotated to CLEC12A) for AWHS and one DHP (annotated to NPLOC4) for FACT remained statistically significant after false discovery rate (FDR) correction. Pathways related to chronic diseases including cardiovascular, cancer and neurological were enriched. CONCLUSIONS: While we identified common 5-hmC and 5-mC signatures in two populations exposed to varying levels of inorganic As, differences in As-related epigenetic sites across the study populations may additionally reflect low and high As-specific associations. This work contributes a deeper understanding of potential epigenetic dysregulations of As. However, further research is needed to confirm biological consequences associated with DIP2C epigenetic regulation and to investigate the role of 5-hmC and 5-mC separately in As-induced health disorders at different exposure levels.


Asunto(s)
Arsénico , Arsénico/toxicidad , Bangladesh , Metilación de ADN , Epigénesis Genética , Humanos , Lectinas Tipo C , Masculino , Proteínas Nucleares , Receptores Mitogénicos , España
3.
J Dairy Sci ; 103(5): 4738-4742, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32113771

RESUMEN

Lameness in dairy cattle is an important health and welfare concern directly affecting the economic benefits of farmers. Although foot dirtiness is a recognized risk factor for diseases inducing lameness, there is a lack of scoring systems that focus specifically on the foot. Therefore, the aim of this study was to evaluate the reliability of a 3-point dirtiness scoring system recently conceived for the assessment of the dirtiness present at the lower legs and claws of dairy cows. The scores of both the lateral and back views from 4 unfamiliar raters at 4 different times were used to evaluate interrater reliability (3 times) and intrarater scoring consistency (1 time). The findings of this investigation revealed that coefficients for interrater agreement (0.38, 0.62 and 0.63) and rating concordance (0.55, 0.75 and 0.74) of back-view scorings improved over time and were superior or similar to those obtained from lateral-view evaluations (coefficients for interrater agreement = 0.20, 0.35, and 0.69; coefficients for rating concordance = 0.48, 0.59, and 0.78). Additionally, the scoring consistency of the raters using the back-view grid was excellent (Cronbach's α = 0.93). The results suggest that the 3-point back-view dirtiness scoring grid may provide dairy consultants and farmers a reliable and easy tool for assessing cow foot dirtiness.


Asunto(s)
Enfermedades de los Bovinos/diagnóstico , Cojera Animal/diagnóstico , Animales , Bovinos , Enfermedades de los Bovinos/fisiopatología , Industria Lechera , Agricultores , Femenino , Pie , Marcha , Higiene , Cojera Animal/fisiopatología , Reproducibilidad de los Resultados , Factores de Riesgo
7.
Biometals ; 28(2): 341-51, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25753946

RESUMEN

Mass spectrometry (MS)-based toxicometabolomics requires analytical approaches for obtaining unbiased metabolic profiles. The present work explores the general application of direct infusion MS using a high mass resolution analyzer (a hybrid systems triple quadrupole-time-of-flight) and a complementary gas chromatography-MS analysis to mitochondria extracts from mouse hepatic cells, emphasizing on mitochondria isolation from hepatic cells with a commercial kit, sample treatment after cell lysis, comprehensive metabolomic analysis and pattern recognition from metabolic profiles. Finally, the metabolomic platform was successfully checked on a case-study based on the exposure experiment of mice Mus musculus to inorganic arsenic during 12 days. Endogenous metabolites alterations were recognized by partial least squares-discriminant analysis. Subsequently, metabolites were identified by combining MS/MS analysis and metabolomics databases. This work reports for the first time the effects of As-exposure on hepatic mitochondria metabolic pathways based on MS, and reveals disturbances in Krebs cycle, ß-oxidation pathway, amino acids degradation and perturbations in creatine levels. This non-target analysis provides extensive metabolic information from mitochondrial organelle, which could be applied to toxicology, pharmacology and clinical studies.


Asunto(s)
Arsénico/toxicidad , Metaboloma/efectos de los fármacos , Mitocondrias Hepáticas/metabolismo , Animales , Redes y Vías Metabólicas , Metabolómica , Ratones Endogámicos BALB C , Mitocondrias Hepáticas/efectos de los fármacos , Espectrometría de Masas en Tándem
8.
Environ Monit Assess ; 187(11): 662, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26431706

RESUMEN

This paper comparatively shows the influence of four water treatment processes on the formation of trihalomethanes (THMs) in a water distribution system. The study was performed from February 2005 to January 2012 with analytical data of 600 samples taken in Aljaraque water treatment plant (WTP) and 16 locations along the water distribution system (WDS) in the region of Andévalo and the coast of Huelva (southwest Spain), a region with significant seasonal and population changes. The comparison of results in the four different processes studied indicated a clear link of the treatment process with the formation of THM along the WDS. The most effective treatment process is preozonation and activated carbon filtration (P3), which is also the most stable under summer temperatures. Experiments also show low levels of THMs with the conventional process of preoxidation with potassium permanganate (P4), delaying the chlorination to the end of the WTP; however, this simple and economical treatment process is less effective and less stable than P3. In this study, strong seasonal variations were obtained (increase of THM from winter to summer of 1.17 to 1.85 times) and a strong spatial variation (1.1 to 1.7 times from WTP to end points of WDS) which largely depends on the treatment process applied. There was also a strong correlation between THM levels and water temperature, contact time and pH. On the other hand, it was found that THM formation is not proportional to the applied chlorine dose in the treatment process, but there is a direct relationship with the accumulated dose of chlorine. Finally, predictive models based on multiple linear regressions are proposed for each treatment process.


Asunto(s)
Agua Potable/química , Trihalometanos/análisis , Contaminantes Químicos del Agua/análisis , Purificación del Agua/métodos , Cloro , Monitoreo del Ambiente , Halogenación , Modelos Teóricos , Estaciones del Año , España , Temperatura , Abastecimiento de Agua
9.
J Antimicrob Chemother ; 69(11): 3020-6, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24962033

RESUMEN

OBJECTIVES: To determine the efficacy of daptomycin for the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis using in vitro and in vivo methods. METHODS: In vitro killing curves were determined with clinically achievable CSF antibiotic concentrations. In a rabbit model of pneumococcal meningitis, we studied the efficacy (Δ cfu/mL) of daptomycin used at 15 and 25 mg/kg, comparing it with ceftriaxone 100 mg/kg/24 h and ceftriaxone plus vancomycin 30 mg/kg/24 h over a 26 h period against two different strains: HUB 2349 and ATCC 51916, with MICs of 2 and 32 mg/L of cefotaxime/ceftriaxone, respectively. RESULTS: The penetration of daptomycin into CSF ranged between 9% and 11%. Daptomycin therapy achieved an excellent response, being bactericidal within 2 h of antibiotic administration. Against strain HUB 2349, daptomycin at both doses was as effective as ceftriaxone plus vancomycin. Against the highly resistant strain, daptomycin 25 mg/kg was significantly better than ceftriaxone plus vancomycin at 2 and 6 h. CONCLUSIONS: Daptomycin at standard doses, and especially at high doses, may be a useful alternative for the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis.


Asunto(s)
Resistencia a las Cefalosporinas/efectos de los fármacos , Cefalosporinas/uso terapéutico , Daptomicina/uso terapéutico , Meningitis Neumocócica/tratamiento farmacológico , Animales , Cefalosporinas/farmacología , Daptomicina/farmacología , Femenino , Meningitis Neumocócica/líquido cefalorraquídeo , Conejos , Resultado del Tratamiento
10.
Infection ; 42(5): 817-27, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24902522

RESUMEN

PURPOSE: To analyse the short-term outcome in patients with Listeria monocytogenes meningoencephalitis (LMME) to improve management and outcome. METHODS: Observational study with adult patients with LMME between 1977 and 2009 at a tertiary hospital in Barcelona, Spain. Parameters that predicted outcome were assessed with univariate and logistic regression analysis. RESULTS: Of 59 cases of LMME, 28 occurred in the last decade. Since 1987, a new protocol has been used and 29/45 patients (64%) treated since then received adjuvant dexamethasone. In patients who received this treatment there was a trend towards fewer neurological sequelae (5 vs 33%; p = 0.052). Antiseizure prophylaxis with phenytoin was administered in 13/45 (28%) patients. Seizures occurred in 7/45 (16%) patients, all in the group who did not receive phenytoin. Hydrocephalus presented in 8/59 (14%). It was never present at admission and five patients needed neurosurgical procedures. Sequelae after 3 months were present in 8/45 (18%), mostly cranial nerve palsy. Rhombencephalitis (RE) was related to the presence of neurologic sequelae (OR: 20.4, 95% CI: 1.76-236). Overall mortality was 14/59 (24%), 9/59 (15%) due to neurological causes related to hydrocephalus or seizures. Mortality was defined as early in 36% and late in 64%. In the multivariate analysis, independent risk factors for mortality were presence of hydrocephalus (OR: 17.8, 95% CI: 2.753-114) and inappropriate empirical antibiotic therapy (OR: 6.5, 95% CI: 1.201-35). CONCLUSIONS: Outcome of LMME may be improved by appropriate empirical antibiotic therapy, suspicion and careful management of hydrocephalus. Use of adjuvant dexamethasone or phenytoin in a subgroup of these patients might have a benefit.


Asunto(s)
Antiinflamatorios/uso terapéutico , Profilaxis Antibiótica , Anticonvulsivantes/uso terapéutico , Dexametasona/uso terapéutico , Hidrocefalia/tratamiento farmacológico , Meningitis por Listeria/tratamiento farmacológico , Convulsiones/tratamiento farmacológico , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Hidrocefalia/microbiología , Hidrocefalia/mortalidad , Listeria monocytogenes/fisiología , Masculino , Meningitis por Listeria/complicaciones , Meningitis por Listeria/microbiología , Meningitis por Listeria/mortalidad , Persona de Mediana Edad , Análisis Multivariante , Pronóstico , Factores de Riesgo , Convulsiones/microbiología , Convulsiones/mortalidad , España/epidemiología
11.
Environ Sci Technol ; 48(14): 7747-55, 2014 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-24922451

RESUMEN

Monitoring organism exposure to heavy metals has acquired increased importance in the last decades. The mouse Mus spretus has been used to assess the biological response to contaminants in the relevant ecological area of Doñana National Park (DNP) and surrounding areas (SW Spain), where many migrating birds land for breeding and feeding every year. A metallomics approach, based on the characterization of metal biomolecules using size exclusion chromatography coupled with inductively coupled plasma-mass spectrometry (SEC-ICP-MS) and a metabolomics approach based on direct infusion to a mass spectrometer (DI-ESI-QTOF-MS) followed by a partial linear square-discriminant analysis (PLS-DA), were used to compare the biological responses of M. spretus living in three areas of DNP (the reference) and surrounding areas (El Partido and El Matochal). The activities of key antioxidant enzymes, such as Cu/Zn-SOD, Mn-SOD, CAT, GR, and guaiacol peroxidase, were also determined in connection with environmental contamination issues. The results show differences caused by the presence of metals in the ecosystem that affected to the levels of metals and metalloproteins, such as MT, Cu/Zn-SOD, or Mn-CA, the breakdown of membrane phospholipids, perturbations in metabolic pathways, related to energy metabolism, and oxidative stress.


Asunto(s)
Monitoreo del Ambiente , Contaminación Ambiental/análisis , Metabolómica , Metales/análisis , Animales , Antioxidantes/metabolismo , Sistema Libre de Células , Cromatografía en Gel , Análisis Discriminante , Riñón/enzimología , Análisis de los Mínimos Cuadrados , Hígado/metabolismo , Ratones , Oxidación-Reducción , España , Espectrometría de Masa por Ionización de Electrospray , Espectrofotometría Atómica , Extractos de Tejidos
12.
Anal Bioanal Chem ; 406(5): 1567-71, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24343454

RESUMEN

The present paper describes a method based on the extraction of analytes by multiple hollow fibre liquid-phase microextraction and detection by ion-trap mass spectrometry and electron capture detectors after gas chromatographic separation. The limits of detection are in the range of 0.13-0.67 µg kg(-1), five orders of magnitude lower than those reached with the European Commission Official method of analysis, with three orders of magnitude of linear range (from the quantification limits to 400 µg kg(-1) for all the analytes) and recoveries in fortified olive oils in the range of 78-104 %. The main advantages of the analytical method are the absence of sample carryover (due to the disposable nature of the membranes), high enrichment factors in the range of 79-488, high throughput and low cost. The repeatability of the analytical method ranged from 8 to 15 % for all the analytes, showing a good performance.


Asunto(s)
Microextracción en Fase Líquida/instrumentación , Aceites de Plantas/química , Solventes/análisis , Cromatografía Líquida de Alta Presión , Cromatografía de Gases y Espectrometría de Masas , Halogenación , Límite de Detección , Microextracción en Fase Líquida/métodos , Membranas Artificiales , Aceite de Oliva , Reproducibilidad de los Resultados
13.
Anal Bioanal Chem ; 406(28): 7137-48, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25230597

RESUMEN

Currently, there is no cure for Alzheimer's disease and early diagnosis is very difficult, since no biomarkers have been established with the necessary reliability and specificity. For the discovery of new biomarkers, the application of omics is emerging, especially metabolomics based on the use of mass spectrometry. In this work, an analytical approach based on direct infusion electrospray mass spectrometry was applied for the first time to blood serum samples in order to elucidate discriminant metabolites. Complementary methodologies of extraction and mass spectrometry analysis were employed for comprehensive metabolic fingerprinting. Finally, the application of multivariate statistical tools allowed us to discriminate Alzheimer patients and healthy controls, and identify some compounds as potential markers of disease. This approach provided a global vision of disease, given that some important metabolic pathways could be studied, such as membrane destabilization processes, oxidative stress, hypometabolism, or neurotransmission alterations. Most remarkable results are the high levels of phospholipids containing saturated fatty acids, respectively, polyunsaturated ones and the high concentration of whole free fatty acids in Alzheimer's serum samples. Thus, these results represent an interesting approximation to understand the pathogenesis of disease and the identification of potential biomarkers.


Asunto(s)
Enfermedad de Alzheimer/sangre , Enfermedad de Alzheimer/diagnóstico , Biomarcadores/análisis , Espectrometría de Masas/métodos , Metaboloma , Metabolómica/métodos , Anciano , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Redes y Vías Metabólicas
14.
Anal Bioanal Chem ; 406(11): 2719-25, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24535684

RESUMEN

A method for the simultaneous speciation of selenoproteins and selenometabolites in mouse plasma has been developed based on in series two-dimensional size exclusion and affinity high-performance liquid chromatography (2D/SE-AF-HPLC), using two columns of each type, and hyphenation to inductively coupled plasma-(quadrupole) mass spectrometry (ICP-QMS). The method allows the quantitative determination of selenoprotein P (SeP), extracellular glutathione peroxidase (eGPx), selenoalbumin (SeAlb), and selenometabolites in mouse plasma using species-unspecific isotope dilution (SUID). The 2D chromatographic separation is proposed to remove typical spectral interferences in plasma from chloride and bromide on (77)Se ((40)Ar(37)Cl) and (82)Se ((81)Br(1)H). In addition, the approach increases chromatographic resolution allowing the separation of eGPx from Se metabolites of low molecular mass. The method is robust, reliable, and fast with a typical chromatographic runtime less than 20 min. Precision in terms of relative standard deviation (n = 5) is in the order of 4 %, and detection limits are in the range of 0.2 to 1.0 ng Se g(-1). Method accuracy for determination of total protein bound to Se was assessed by analyzing human serum reference material (BCR-637) certified for total Se content, and latterly applied to mouse plasma (Mus musculus). In summary, a reliable speciation method for the analysis of eGPx, selenometabolites, SeP, and SeAlb in plasma/serum samples is proposed for the first time and is applicable to the evaluation of Se status in human in clinical studies and other mammals for environmental or toxicological assessment.


Asunto(s)
Cromatografía de Afinidad/métodos , Cromatografía en Gel/métodos , Espectrometría de Masas/métodos , Selenoproteínas/sangre , Animales , Humanos , Ratones , Plasma/química , Selenoproteínas/aislamiento & purificación , Selenoproteínas/metabolismo , Suero/química
15.
Anal Bioanal Chem ; 406(5): 1455-69, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24448970

RESUMEN

The mechanism of arsenic toxicity still remains unclear, although enzymatic inhibition, impaired antioxidants metabolism and oxidative stress may play a role. The toxicological effects of trivalent inorganic arsenic on laboratory mouse Mus musculus after oral administration (3 mg/kg body weight/day) were investigated along 12 days, using a metabolomic approach based on direct infusion mass spectrometry to polar and lipophilic extracts from different organs and fluids (liver, kidney, and plasma). Positive and negative acquisition modes (ESI(+)/ESI(-)) were used throughout the experiments. The most significant endogenous metabolites affected by exposure were traced by partial least square-discriminant analysis and confirmed by tandem mass spectrometry (MS/MS) and gas chromatography coupled to MS. In this work, the toxic effect of arsenic has been related with important metabolic pathways, such as energy metabolism (e.g., glycolysis, Krebs cycle), amino acids metabolism, choline metabolism, methionine cycle, and degradation of membrane phospholipids (cell apoptosis). In addition, this work illustrates the high reliability of mass spectrometry based on a metabolomic approach to study the biochemical effects induced by metal exposure.


Asunto(s)
Arsenicales/sangre , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Metabolómica , Óxidos/sangre , Espectrometría de Masa por Ionización de Electrospray/métodos , Administración Oral , Aminoácidos/metabolismo , Animales , Trióxido de Arsénico , Arsenicales/farmacocinética , Colina/metabolismo , Metabolismo Energético/efectos de los fármacos , Riñón/metabolismo , Hígado/metabolismo , Metionina/metabolismo , Ratones , Ratones Endogámicos BALB C , Óxidos/farmacocinética , Óxidos/toxicidad , Fosfolípidos/metabolismo
16.
Infect Dis (Lond) ; 56(11): 974-982, 2024 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-38922314

RESUMEN

OBJECTIVES: This study details the accumulated experience of more than 31 years using a low-dose systematic dexamethasone protocol with mannitol and antiseizure prophylaxis for the treatment of suspected pneumococcal meningitis. METHODS: Data have been prospectively collected for the period1977-2018. From 1987, patients with suspected pneumococcal meningitis received 12 mg dexamethasone followed by 4 mg/6 h for 48 h, started before or with the first antibiotic dose. They also received (1) a single intravenous dose of 0.5-1 g/Kg mannitol, and (2) antiseizure prophylaxis with phenytoin. RESULTS: In total, 363 episodes of pneumococcal meningitis were recorded. Of these, 242 were treated with the dexamethasone protocol after 1987 and 121 were treated without the protocol. Overall mortality was 11.6% (28/242) among patients treated with dexamethasone and 35% (43/121) among those treated without dexamethasone (p = 0.000). Early mortality was significantly lower at 5.8% (14/242) with dexamethasone and 24% (29/121) without dexamethasone (p = 0.000). Finally, neurological mortality was significantly lower at 7.4% (18/242) with dexamethasone and 23% (28/121) without dexamethasone (p = 0.000). CONCLUSIONS: A low dose of dexamethasone along with a single dose of mannitol and antiseizures prophylaxis might be useful for reducing both overall and early mortality in pneumococcal meningitis in adult patients.


Asunto(s)
Dexametasona , Manitol , Meningitis Neumocócica , Dexametasona/administración & dosificación , Dexametasona/uso terapéutico , Humanos , Manitol/administración & dosificación , Manitol/uso terapéutico , Meningitis Neumocócica/prevención & control , Meningitis Neumocócica/mortalidad , Meningitis Neumocócica/tratamiento farmacológico , Masculino , Femenino , Persona de Mediana Edad , Adulto , Anciano , Pronóstico , Anticonvulsivantes/administración & dosificación , Anticonvulsivantes/uso terapéutico , Adulto Joven , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Adolescente , Estudios Prospectivos , Anciano de 80 o más Años
17.
Antimicrob Agents Chemother ; 57(1): 606-10, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23089756

RESUMEN

The efficacy of daptomycin, imipenem, or rifampin with fosfomycin was evaluated and compared with that of daptomycin-rifampin in a tissue cage model infection caused by methicillin-resistant Staphylococcus aureus (MRSA). Strain HUSA 304 was used. The study yielded the following results for MICs (in µg/ml): fosfomycin, 4; daptomycin, 1; imipenem, 0.25; and rifampin, 0.03. The study yielded the following results for minimum bactericidal concentration (MBC) (in µg/ml): fosfomycin, 8; daptomycin, 4; imipenem, 32; and rifampin, 0.5. Daptomycin-rifampin was confirmed as the most effective therapy against MRSA foreign-body infections. Fosfomycin combinations with high doses of daptomycin and rifampin were efficacious alternative therapies in this setting. Fosfomycin-imipenem was relatively ineffective and did not protect against resistance.


Asunto(s)
Antibacterianos/farmacología , Daptomicina/farmacología , Reacción a Cuerpo Extraño/tratamiento farmacológico , Fosfomicina/farmacología , Imipenem/farmacología , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Rifampin/farmacología , Infecciones Estafilocócicas/tratamiento farmacológico , Animales , Antibacterianos/sangre , Antibacterianos/farmacocinética , Recuento de Colonia Microbiana , Daptomicina/sangre , Daptomicina/farmacocinética , Modelos Animales de Enfermedad , Combinación de Medicamentos , Farmacorresistencia Bacteriana , Reacción a Cuerpo Extraño/sangre , Reacción a Cuerpo Extraño/microbiología , Fosfomicina/sangre , Fosfomicina/farmacocinética , Imipenem/sangre , Imipenem/farmacocinética , Staphylococcus aureus Resistente a Meticilina/crecimiento & desarrollo , Pruebas de Sensibilidad Microbiana , Ratas , Ratas Wistar , Rifampin/sangre , Rifampin/farmacocinética , Infecciones Estafilocócicas/sangre , Infecciones Estafilocócicas/microbiología
18.
Eur J Clin Microbiol Infect Dis ; 32(3): 413-20, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23344827

RESUMEN

The prevalence of multidrug-resistant (MDR) Pseudomonas aeruginosa has increased over the past decade and a significant rise in these isolates in ventilator-associated pneumonia (VAP) has been observed. However, the impact of MDR on VAP outcome has not been analysed in depth. We investigated the risk factors for early and crude mortality in a retrospective study of microbiologically and clinically documented VAP. Ninety-one VAP episodes in 83 patients were included, 31 caused by susceptible P. aeruginosa and 60 by MDR strains, of which 42 (70 %) were extensively drug-resistant (XDR) P. aeruginosa. Thirteen episodes concomitantly presented P. aeruginosa bacteraemia, in seven of which the origin was the respiratory tract. Whereas susceptible P. aeruginosa episodes were more likely than MDR episodes to receive adequate empirical (68 % vs. 30 %; p < 0.001) and definitive antimicrobial therapy (96 % vs. 50 %; p < 0.001), susceptible P. aeruginosa VAP presented a trend towards early mortality (29 % vs. 15 %; p = 0.06). A logistic regression model with early mortality as the dependent variable identified multiorgan dysfunction syndrome (MODS) [odds ratio (OR) 10.4; 95 % confidence interval (CI) 1.7-63.5; p = 0.01] and inadequate antibiotic therapy (OR 4.27; 95 % CI 0.98-18.4; p = 0.052) as independent risk factors for early mortality. A similar analysis identified MODS (OR 4.31; 95 % CI 1.14-16.2; p = 0.03) as the only independent predictor of crude mortality. The severity of acute illness clinical presentation was the main predictor of mortality. Despite adequate antibiotic therapy, susceptible P. aeruginosa seems to cause major early mortality. Although adequate therapy is essential to treat VAP, the severity of acute illness is a more important factor than drug resistance.


Asunto(s)
Antibacterianos/uso terapéutico , Neumonía Asociada al Ventilador/epidemiología , Neumonía Asociada al Ventilador/mortalidad , Infecciones por Pseudomonas/epidemiología , Infecciones por Pseudomonas/mortalidad , Pseudomonas aeruginosa/efectos de los fármacos , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/farmacología , Farmacorresistencia Bacteriana Múltiple , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neumonía Asociada al Ventilador/microbiología , Neumonía Asociada al Ventilador/patología , Pronóstico , Infecciones por Pseudomonas/microbiología , Infecciones por Pseudomonas/patología , Pseudomonas aeruginosa/aislamiento & purificación , Estudios Retrospectivos , Factores de Riesgo , Análisis de Supervivencia , Resultado del Tratamiento
19.
Biometals ; 26(4): 639-50, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23793301

RESUMEN

Characterization of Cd-binding proteins has great analytical interest due to the high toxicity of Cd to living organisms. Metallothioneins (MTs), as Cd(II)-binding proteins are of increasing interest, since they form very stable Cd chelates and are involved in many detoxification processes. In this work, inductively coupled plasma octopole reaction cell mass spectrometry and nanospray ionization time-of-flight mass spectrometry were used in parallel and combined with two-dimensional chromatography: size exclusion followed by reversed-phase high performance liquid chromatography, to study metal complexes of MT isoforms produced in hepatic cytosols of Mus musculus during exposure experiments to Cd. Exposure experiments were carried out by subcutaneous injection of a growing dose of the toxic element ranging from 0.1 to 1.0 mg of Cd per kg of body weight per day during 10 days. A control group and three exposure groups at days 2, 6 and 10 of exposure were studied, and different cadmium, copper and zinc complexes with MTs isoforms were isolated and characterized from the two most exposed groups. The results allow gaining insight into the mechanisms involved in metal detoxification by MTs, showing the changes in the stoichiometry of metal complexes-MTs along cadmium exposure.


Asunto(s)
Cadmio/toxicidad , Hepatocitos/metabolismo , Metalotioneína/metabolismo , Isoformas de Proteínas/metabolismo , Animales , Cadmio/metabolismo , Hepatocitos/efectos de los fármacos , Ratones , Ratones Endogámicos BALB C
20.
Biometals ; 26(4): 651-66, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23780566

RESUMEN

A metallomic analytical approach based on the use of size exclusion chromatography coupled to ICP-MS has been used to obtain metal profiles related to overexpression or inhibition of metal-binding biomolecules, which is connected to exposure experiment of laboratory mice Mus musculus to toxic metals, such as Cd, Hg and As. Exposure to Cd induces the formation of Cd-metallothionein in liver that reveals the protective role of this organ; however, exposure to Hg reduces the intensity of the peak associated to Cu-superoxide dismutase (Cu-SOD) while Hg-SOD peak increases, which suggests the competence of Cu and Hg for the active sites of SOD in liver that causes mercury translocation to kidney, in which the concentration of Hg as Hg-metallothionein increases drastically to be excreted by urine. It has been also observed the protective effect of selenium on mercury toxicity in blood plasma, which produces decreasing of the intensity of Se-protein in plasma with Hg exposure and correlative increases of Hg-albumin that transport mercury to kidney for excretion. Finally, arsenic exposure provokes the accumulation of small metabolites of this element, such as dimethylarsenic and monomethylarsenic for excretion. The application of the metallomic approach to liver extracts from free-living mouse Mus spretus shows the overexpression of Cu, Zn and Cd-peaks at 7 kDa (related to metal-metallothionein) in environmental contaminated sites, as well as the increase of peaks related to Cu- and Zn-SOD and Zn-albumin. However, in kidney, can be checked the presence of high concentration of arsenic small metabolites in contaminated areas, similarly to results found in exposure experiments. In addition, the application of a metabolomic approach based on direct infusion mass spectrometry to organ extracts (liver, kidney and serum) from mice (M. musculus) exposed to arsenic reveals important metabolic changes related to antioxidative activity, membrane cell damage, energy metabolism and arsenic elimination. Similar results were obtained from free-living mouse (M. spretus) from areas contaminated with arsenic. The integration of metallomics and metabolomics results provides a more comprehensive evaluation about the biological response in exposure experiments to toxic metals as well as in environmental assessment of contamination.


Asunto(s)
Metales/metabolismo , Metales/toxicidad , Animales , Exposición a Riesgos Ambientales/efectos adversos , Riñón/efectos de los fármacos , Riñón/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Espectrometría de Masas , Metabolómica , Ratones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA